Market Overview:
Leukapheresis devices are specialized medical instruments used in leukapheresis procedures to collect white blood cells from patient’s blood for further use in cancer treatment procedures such as hematopoietic stem cell transplantation. These devices help separate and collect white blood cells from blood in a less invasive and customized way which benefits patients undergoing leukapheresis.
Market key trends:
Growing R&D in leukapheresis for various disease applications is expected to boost the market growth during the forecast period. Leading players are focusing on expanding use of leukapheresis through ongoing clinical trials to collect leukocytes from blood for treating several autoimmune diseases and graft-versus-host disease (GVHD). For instance, Haemonetics Corporation is investigating use of leukapheresis in malaria, sepsis and respiratory viral infections treatment. Similarly, STEMCELL Technologies Inc. has ongoing clinical studies evaluating use of leukapheresis in chronic inflammatory diseases such as kidney diseases.
Segment Analysis
The global leukapheresis devices market is segmented into disposable leukapheresis kits and leukapheresis machines. The disposable leukapheresis kits segment dominates the market, owing to higher adoption of single-use kits that prevent cross-contamination during procedures. Disposable kits are convenient and ensure sterility.
Key Takeaways
The global Leukapheresis Devices Market Demand is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period, due to increasing demand for leukapheresis procedures for treating leukemia and collecting stem cells.
Regional analysis
North America dominates the global leukapheresis devices market owing to rising incidence of blood-related disorders and developed healthcare infrastructure in the region. It is expected to maintain its dominance over the forecast period.
Key players
Key players operating in the leukapheresis devices market are Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA. Asahi Kasei Medical Co. Ltd. and Haemonetics Corporation dominate the market owing to their wide product portfolio and global presence.
Read More:
